David M. Simon

432 total citations
8 papers, 284 citations indexed

About

David M. Simon is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, David M. Simon has authored 8 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in David M. Simon's work include Cytomegalovirus and herpesvirus research (4 papers), Herpesvirus Infections and Treatments (2 papers) and Viral-associated cancers and disorders (2 papers). David M. Simon is often cited by papers focused on Cytomegalovirus and herpesvirus research (4 papers), Herpesvirus Infections and Treatments (2 papers) and Viral-associated cancers and disorders (2 papers). David M. Simon collaborates with scholars based in United States, Russia and Canada. David M. Simon's co-authors include Stuart Levin, Gordon M. Trenholme, Gina L. Koenig, Steven Zimmerly, Scot A. Kelchner, Matthew J. Kuehnert, Anna Grigoryan, Craig Conover, J. Michael Millis and John J. Friedewald and has published in prestigious journals such as The Journal of Infectious Diseases, Molecular Biology and Evolution and American Journal of Transplantation.

In The Last Decade

David M. Simon

8 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Simon United States 8 157 61 55 47 41 8 284
Marta Peracchi Italy 9 199 1.3× 11 0.2× 101 1.8× 9 0.2× 34 0.8× 15 328
Esther Voigt Germany 12 145 0.9× 41 0.7× 256 4.7× 158 3.4× 25 0.6× 19 432
Derya Mutlu Türkiye 9 72 0.5× 157 2.6× 60 1.1× 30 0.6× 55 1.3× 44 394
Dima Kabbani Canada 10 209 1.3× 16 0.3× 165 3.0× 6 0.1× 13 0.3× 39 323
Frances M. Saccoccio United States 9 165 1.1× 95 1.6× 63 1.1× 9 0.2× 31 0.8× 14 353
R. Lattes Argentina 10 331 2.1× 18 0.3× 189 3.4× 14 0.3× 16 0.4× 13 402
Ángel Bulnes‐Ramos Spain 8 101 0.6× 17 0.3× 106 1.9× 22 0.5× 70 1.7× 14 283
Marianne Leruez France 9 32 0.2× 75 1.2× 73 1.3× 4 0.1× 16 0.4× 14 251
J. M. Aguado Spain 9 135 0.9× 15 0.2× 70 1.3× 10 0.2× 5 0.1× 16 224
Tonya Hayden United States 8 172 1.1× 33 0.5× 42 0.8× 198 4.2× 26 0.6× 12 327

Countries citing papers authored by David M. Simon

Since Specialization
Citations

This map shows the geographic impact of David M. Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Simon more than expected).

Fields of papers citing papers by David M. Simon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Simon. The network helps show where David M. Simon may publish in the future.

Co-authorship network of co-authors of David M. Simon

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Simon. A scholar is included among the top collaborators of David M. Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Simon. David M. Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lieber, Richard L., Anne-Mette C. Sauër, Jennifer Poirier, et al.. (2016). Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease. Transplantation Proceedings. 48(6). 2056–2064.e1. 10 indexed citations
3.
Ison, Michael G., Eloisa Llata, Craig Conover, et al.. (2011). Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ Donor to Four Transplant Recipients. American Journal of Transplantation. 11(6). 1218–1225. 80 indexed citations
4.
Hoang, Quan V., et al.. (2010). Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV. Graefe s Archive for Clinical and Experimental Ophthalmology. 248(5). 737–740. 9 indexed citations
5.
Simon, David M., Scot A. Kelchner, & Steven Zimmerly. (2009). A Broadscale Phylogenetic Analysis of Group II Intron RNAs and Intron-Encoded Reverse Transcriptases. Molecular Biology and Evolution. 26(12). 2795–2808. 26 indexed citations
6.
Sha, Beverly E., et al.. (2006). Herpes simplex virus hepatitis: expanding the spectrum of disease. Transplant Infectious Disease. 8(3). 171–176. 13 indexed citations
7.
Simon, David M. & Stuart Levin. (2001). INFECTIOUS COMPLICATIONS OF SOLID ORGAN TRANSPLANTATIONS. Infectious Disease Clinics of North America. 15(2). 521–549. 76 indexed citations
8.
Simon, David M., Gina L. Koenig, & Gordon M. Trenholme. (1991). Differences in Release of Tumor Necrosis Factor from THP-l Cells Stimulated by Filtrates of Antibiotic-Killed Escherichia coli. The Journal of Infectious Diseases. 164(4). 800–802. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026